Prescription Drug User Fee Act (PDUFA) target date of October 2026 -- -- Submission supported by CESSA Phase 3 trial results demonstrating statistically significant rates of clinical remission in ...
Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will present its abstract evaluating the impact of ...
A writer shares how vulvodynia, a chronic condition that causes vaginal pain, impacted her sex life and how she learned to ...
There isn’t enough research about the vaginal microbiome. But that doesn’t mean you need ‘feminine probiotics’ that companies are pushing ...
The Subaru X-100 represents a rare moment where corporate desperation and genuine aerodynamic obsession collided to produce ...
A Goldman Sachs veteran says this platform would have funded faster as a rectal drug. Merck disagreed. Here's what took so ...
Despite how prevalent and uncomfortable they can be, yeast infections are usually manageable with the right care.
These three products from ‘intimate care’ brand, Juice, contain ‘self-care melts’. At £45 a pop, they’re essentially small ...
In March, Pharmaceutical Executive reported on Eli Lilly’s efforts to push back against the availability of compounded GLP-1 ...
"I was in medical school on inpatient psych. This happened right before I started the rotation, so I didn't see it firsthand, ...
First up, you’ll be given some pain relief – either a regional or general anaesthetic – and a catheter is fitted. Your ...
Faster charging, new batteries, and a radical steering system could finally change the EQS story.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results